NORFOLK, Va. (WAVY) — Sarcoma, one of the rarest cancers in the world, makes up just 1% of all adult cancer diagnoses, but it is widely recognized as the ‘forgotten cancer,’ putting emphasis on just ...

HONOLULU (KHON2) — July is National Sarcoma Awareness Month, a time to recognize the signs of this rare type of cancer that affects about 17,000 people in the U.S. every year. Sarcoma is a cancer that ...

The FDA's orphan drug designation supports LP-284's development for soft tissue sarcomas, addressing significant unmet needs in this adult patient population. The FDA granted orphan drug designation ...

SOME SHOWERS. ALL RIGHT, THANK YOU. ETHAN. WELL, JULIA SARCOMA AWARENESS MONTH AND I’M PLEASED TO BE JOINED BY DOCTOR KURT WEISS. HE’S WITH UPMC AND ORTHOPEDIC SURGEON. AND I UNDERSTAND DOCTOR WEISS, ...

Ewing sarcoma treatments include chemotherapy, surgery, radiation therapy, and stem cell transplants. Ewing sarcoma is a rare and aggressive cancer that typically develops in the bones or the soft ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...

Ewing sarcoma develops due to genetic causes that include changes to a person’s DNA and chromosomes. It more often affects teenagers and young adults, males, and white people. The exact cause of Ewing ...

The phase 1/2 SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced soft tissue sarcoma. The study investigators from City of Hope ...